Novotech at ESMO Congress 2022 – New Data Shows 100% Oncology Trials Growth in APAC ACN Newswire

Novotech at ESMO Congress 2022 – New Data Shows 100% Oncology Trials Growth in APAC

SYDNEY, Sep 5, 2022 - (ACN Newswire via SEAPRWire.com) - Novotech, the leading Asia Pacific biotech specialist CRO, will attend ESMO Congress 2022 with new data showing Asia Pacific has seen a 100% growth in oncology trials during 2017 to 2021 and contributes to more than a third of the global clinical development of immune-oncology drugs.Novotech has experienced CRO operations across APAC and the US offering a unique and unparalleled suite of services for early to late phase biotech clinical research.The clinical data compiled by GlobalData for Novoteoch also found that: "By the end of 2021 40% of active immuno-oncology clinical trials involved at least one location in the Asia-Pacific region, with majority of trials conducted in China, followed by Australia, South Korea, Japan and Taiwan. In the APAC region, the proportion of oncology trials doubled during 2017-2021. In China, the growth in oncology trials was associated with a significant increase in cancer incidence, development of innovative products by domestic companies, focus on immune-oncology, and leadership in cell therapy."Download the Reports Here:IMMUNO-ONCOLOGY - ASIA PACIFIC - CLINICAL TRIAL LANDSCAPE https://novotech-cro.com/whitepapers/immuno-oncology-asia-pacific-clinical-trial-landscapeEVOLUTION OF CLINICAL TRIALS IN THE ASIA PACIFIC REGION COMPARED TO THE US AND THE EU5 https://novotech-cro.com/whitepapers/evolution-clinical-trials-asia-pacific-region-compared-us-and-eu5According to Yooni Kim, Vice President, Global Clinical Services Novotech: "Asia-Pacific offers a compelling solution for expedited clinical trials with its vast patient populations, less competitive clinical trial landscape, and world-class KOLs, in addition, regulatory reforms have accelerated approval processes. Novotech's service delivery model is tailored to the needs of biotech clients. Our local teams have exceptional site and investigator access, our project management approach emphasizes problem-solving, ownership and flexibility, and our investments in data and technology ensure clients have real-time access to trial performance."Novotech has recently been benchmarked as a top 10 CRO among the world's leading CROs, and has signed 45 Leading Site Partnership agreements over the last 3 years.About Novotech Novotech is the leading Asia-Pacific biotech specialist CRO. Novotech has integrated labs and phase I facilities and provides drug development consulting and clinical development services across all phases. It has been instrumental in the success of approximately 4,000 clinical trials across a broad range of therapeutic areas. Novotech is well-positioned to serve biopharma clients conducting clinical trials in Asia-Pacific and the US. For more information visit https://novotech-cro.com/contactMedia ContactDavid JamesE: communications@novotech-cro.comAU: +61 2 8218 2144 USA: +1 415 951 3228Asia: +65 3159 3427 Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
TOYOTA GAZOO Racing Heading Home to Fuji JCN Newswire

TOYOTA GAZOO Racing Heading Home to Fuji

TOKYO, Sep 5, 2022 - (JCN Newswire via SEAPRWire.com) - TOYOTA GAZOO Racing's GR010 HYBRID Hypercar will make its home debut when the FIA World Endurance Championship (WEC) returns to Japan for the 6 Hours of Fuji after a three-year absence.The penultimate round of the 2022 WEC season sees the series return to Fuji Speedway, located 100km west of Tokyo, for the first time since October 2019 and TOYOTA GAZOO Racing targets a fifth consecutive victory on its home track. Close competition over the first four races of the season sees TOYOTA GAZOO Racing lead the manufacturers' standings by 15 points from Alpine following a dramatic 6 Hours of Monza in July. The 2022 Le Mans winners Sebastien Buemi, Brendon Hartley and Ryo Hirakawa, in the #8 GR010 HYBRID, were runners-up in Italy and are second in the drivers' championship, 10 points behind the leading Alpine crew. Reigning champions Mike Conway, Kamui Kobayashi and Jose Maria Lopez finished third at Monza after having contact with another car whilst leading the race, and they aim for a second win of the year in their #7 GR010 HYBRID. Both Kamui and Ryo have already raced at Fuji Speedway this year, in Super Formula. Ryo won the season-opening race there in April to add to his Super GT victory there in 2020. The GR010 HYBRID will race for the first time in front of Japanese fans and partners this weekend, although the 2021 Le Mans-winning example has been exhibited around the country since it made history by becoming the first Hypercar to win at La Sarthe. Fuji Speedway is more than a home race for the team. The hybrid powertrain in the GR010 HYBRID is designed, developed and built just a few kilometres from the track and, for many colleagues from Higashi-Fuji Technical Center, this weekend's race is their first chance to see the car in action. The 4.563km track, which is the shortest on the WEC calendar despite its 1.5km start-finish straight, is also the most successful circuit for TOYOTA GAZOO Racing, which has won seven of the eight WEC races, missing out on the top step of the podium only in a difficult 2015 season. Historically, Fuji Speedway played a significant role in Toyota's endurance racing development. The iconic 2000GT sportscar showed its speed with wins in the 1967 24-hour and 1000km races, whilst the Toyota 7 wrote itself into legend with fearsome performances there, including victories in the Fuji 1000km in 1968 and 1969. The All Japan Sports Prototype Championship, a national series for Le Mans-style cars, brought Toyota back into front-line sportscar competition in the 1980s and it became a regular winner at Fuji Speedway, which also hosted Japan's first World Sportscar Championship race in 1982. The circuit, on the foothills of Mount Fuji, was upgraded in 2005 and, while the track lay-out remains unchanged since the first modern WEC race there in 2012, the surroundings will look different thanks to the development of a new motorsport resort, including museum, driving centre, visitor entertainment and hotel. The always-enthusiastic Japanese fans get their first chance to see the Hypercars at Fuji Speedway on Friday, when two 90-minute practice sessions are scheduled. Final practice on Saturday prepares the teams for an early afternoon qualifying, while the race begins at 11am local time on Sunday, 4am CEST.For more information, visit https://toyotagazooracing.com/wec/release/2022/rd05-preview/. Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)
More
DECOMAN from Hong Kong Utilizes Technologies to Go Global, Two More Markets in the APAC Region this year ACN Newswire

DECOMAN from Hong Kong Utilizes Technologies to Go Global, Two More Markets in the APAC Region this year

SEOUL, SOUTH KOREA, Sep 5, 2022 - (ACN Newswire via SEAPRWire.com) - HK DECOMAN Technology Limited ("DECOMAN") is now expanding its footprint in Korea to capture the opportunities of growing demand for its services. With the Taiwan expansion begun in January, this is the second APAC market DECOMAN entered in 2022.Coworking space at the KSGC campusCoworking office shared between talented entrepreneurs and promising startups selected by KSGCPen Ventures and DECOMAN in KoreaRecognized by Korean Government's Accelerator ProgramOut of 2,653 companies applying from 122 countries, DECOMAN is among the top 54 startups this year selected by K-Startup Grand Challenge ("KSGC"), a global startup accelerator program organized and financed by the Korean government, to enhance the local entrepreneurship ecosystem. As a KSGC participant, DECOMAN team has been utilizing the facilities and coworking spaces at the KSGC campus in Pangyo Techno Valley - a technology hub near Seoul, to build its K-network and foundation.Support from International VC FirmIn addition to the guidance and opportunities that DECOMAN can gain from KSGC, California venture capital firm Pen Ventures also sails along the journey (read coverage here https://www.fnnews.com/news/202208160811387147 ) with DECOMAN by being its mentor and sharing its extensive network. In the coming months, DECOMAN will make solid progress in respect of its planned road map.Proven Success in Taiwan ExpansionEarlier this year, DECOMAN has already entered Taiwan and debuted on the stage of SparkLabs Taipei DemoDay 6 (read coverage here https://meet-global.bnext.com.tw/articles/view/47581 ), kicking off its operation there and bringing innovation to the renovation market.Expand despite the PandemicIn 2021, DECOMAN received investments from international startup accelerator SparkLabs Taipei, and was invited to participate in SparkLabs Taipei DemoDay 6 in January 2022. DECOMAN has since been in discussion with several local investors to prepare for the next stages. As of now, the renovation-design matching service and "Deco Academy" courses have already been introduced to the locals. Notwithstanding the impacts of the pandemic, DECOMAN has made a strong foundation in Taiwan by recruiting Taiwanese staff to enable rapid executions adaptable to local lifestyles as well as concrete social media presence for content sharing.About DECOMANDECOMAN is a fast-growing one-stop O2O renovation platform, aiming to disrupt the traditional renovation industry by bringing standardization, transparency, convenience and automation to the industry. DECOMAN does it all. With DECOMAN, homeowners no longer need to rely on risky and primitive ways to ascertain a company's credibility and quality of service, nor do they need to worry about mastering a wide range of knowledge for a one-time project. DECOMAN has been backed by large players in the property industry and is currently valued at US$27M. (Visit our websites to know more - Hong Kong https://hkdecoman.com/; Singapore https://www.sgdecoman.com/; Taiwan https://twdecoman.com/; Macau https://modecoman.com/; Korea https://krdecoman.com/ko/)For media enquiries, please contactPinky Hui at pinky_hui@hkdecoman.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More

三一国际(00631.HK)公布中期业绩,收入大增53.1%,国际化拓展成效显著

HONG KONG, Sep 5, 2022 - (亚太商讯 via SEAPRWire.com) - 国内领先的矿山装备及物流装备制造商三一国际(00631.HK)公布2022年度中期业绩。公告显示,截止2022年6月30日,公司实现营业收入约76.3亿元,同比大增53.1%;净利润约9.1亿元,同比增长11.7%。剔除2021年出售新疆子公司的1.5亿元一次性收益影响,净利润的增速达37.1%。在营业收入大幅增长的同时,国际销售也迎来爆发式增长,收入达19.3亿元,同比大增121.9%。根据公司业绩公告,报告期内,全国煤矿智能化建设全面提速,矿山智能化技术加快应用,国家持续推进港口绿色发展规划,公司以电动化、智能化的科技创新产品助推全球矿山及港口建设。同时,公司持续推进国际化、电动化及数智化战略,经营业绩大幅增长,经营质量持续改善。国际化方面,公司坚持「以我为主,本土经营,服务先行,平台赋能」的国际化战略,国际化拓展进程加快,销售实现大幅增长。其中,矿山装备国际销售大增130.9%,宽体车国际销售增长迅速,国内出口市占率第一。物流装备持续拓展欧美、东南亚市场,国际销售大幅增长113.6%。研发方面持续致力于提高智能化、电动化、国际化新品以及数据、算法、软件等方面的研发能力,并在无人驾驶、智能港口及机器人领域持续投入。上半年,研发费用增长23.9%,研发费用率达5.5%。上半年,公司智能化、电动化研发成果显著。智能掘进机井下性能优越,自动化使用率高达72%。采煤机薄煤层及中厚煤层型谱进一步完善。中大吨位SKT105S宽体车实现批量销售,并持续加快新能源宽体车的研发落地。批量交付自动化轨道吊和轮胎吊。中标厦门港海天码头自动化岸桥项目。完成无人平板车全作业场景的路测,自动驾驶和智能化水平行业领先。布局电动正面吊、电动堆高机、电动集卡、电动抓钢料机、电动重叉等全系列电动港口设备等。新业务方面,机器人业务营业收入5.5亿元,同比增长36.9%,AGV、系统集成及立库实现新能源、光伏、化工、电池拆解及离散制造业等行业突破。智矿业务无人驾驶宽体车已在3个矿山开展无人驾驶商业合作,累计完成50台无人驾驶车辆部署,运营里程10万公里,电动化车队运营规模国内第一。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
Society Pass (Nasdaq: SOPA) Founder, Chairman and CEO, Dennis Nguyen, to Speak at the Wild Digital Southeast Asia 2022 Conference on 07 September 2022 ACN Newswire

Society Pass (Nasdaq: SOPA) Founder, Chairman and CEO, Dennis Nguyen, to Speak at the Wild Digital Southeast Asia 2022 Conference on 07 September 2022

SINGAPORE, Sep 5, 2022 - (ACN Newswire via SEAPRWire.com) - Society Pass Incorporated (Nasdaq: SOPA) ("SoPa"), Southeast Asia's ("SEA") leading data-driven loyalty and e-commerce ecosystem, today announced that Founder, Chairman and Chief Executive Officer, Dennis Nguyen will speak at the Wild Digital Southeast Asia 2022 Conference at 11:30 AM (GMT +8) on Wednesday, 07 September 2022 at Le Meridien Kuala Lumpur, Malaysia. He will participate in the panel discussion titled The New Roll-Up Play: Evolution of Ecommerce Aggregators in SEA. Bringing together some of the eCommerce roll-up industry's most influential thought leaders for the panel discussion, Mr Nguyen along with the other speakers will explore the core trends and technologies shaping the future of digital eCommerce aggregators, strategies for maintaining industry dominance in SEA as well as how one can gear up to a successful exit.Southeast Asia presents huge opportunities given the rapidly increasing mobile and internet penetration in the region, paired with very attractive young demographics. The market opportunity for e-commerce companies is expanding at an ever-increasing rate in SEA, where a surge in digital adoption is driving user and merchant uptake as well as creating new technologies and accompanying business models.Society Pass's success up to this point has been built through offering unique value for both consumers and merchants, along with a sophisticated software infrastructure supporting that exchange. Society Pass consumers easily search and order anything they want through the Company's various interconnected mobile and web platforms. Society Pass's strategic alliances, delivery arrangements, and payment processing are also done within the platform, reducing the inconvenience of checkout for consumers.About Society Pass IncFounded in 2018 as a digitally-focused loyalty and data marketing ecosystem in the fast-growing markets of Vietnam, Indonesia, Philippines, Singapore and Thailand, which account for more than 80% of the SEA population, and with offices located in Angeles, Bangkok, Hanoi, Ho Chi Minh City, Jakarta, Manila, and Singapore, SoPa is an acquisition-focused e-commerce holding company operating 6 interconnected verticals (loyalty, digital media, travel, telecoms, lifestyle, and F&B), which seamlessly connects millions of registered consumers and hundreds of thousands of registered merchants/brands across multiple product and service categories throughout SEA.Society Pass completed an initial public offering and began trading on the Nasdaq under the ticker SOPA in November 2021. SOPA shares were added to the Russell 2000 index in December 2021.SoPa acquires fast growing e-commerce companies and expands its user base across a robust product and service ecosystem. SoPa integrates these complementary businesses through its Society Pass loyalty platform and circulation of its universal loyalty points or Society Points, which has entered beta testing and is expected to launch broadly at the beginning of 2023. Society Pass loyalty program members earn and redeem Society Points and receive personalised promotions based on SoPa's data capabilities and understanding of consumer shopping behaviour. SoPa has amassed more than 3.3 million registered consumers and over 205,000 registered merchants and brands. It has invested 2+ years building proprietary IT architecture to effectively scale and support its consumers, merchants, and acquisitions. Society Pass leverages technology to tailor a more personalised experience for customers in the purchase journey and to transform the entire retail value chain in SEA. SoPa operates Thoughtful Media Group, a Thailand-based, a social commerce-focused, premium digital video multi-platform network; NusaTrip, a leading Indonesia-based Online Travel Agency; Gorilla Networks, a Singapore-based, web3-enabled mobile blockchain network operator; Leflair.com, Vietnam's leading lifestyle e-commerce platform; Pushkart.ph, a popular grocery delivery company in Philippines; Handycart.vn, a leading online restaurant delivery service based in Vietnam; and Mangan, a leading local restaurant delivery service in Philippines. For more information, please check out: http://thesocietypass.com/.Media Contacts:PRecious Communicationssopa@preciouscomms.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More

和铂医药-B(02142.HK):营收大增11.5倍,多管线获重大突破,显现巨大创新力

EQS 新闻 via SEAPRWire.com / 2022-09-05 / 10:27 UTC+8 和铂医药-B(02142.HK):营收大增11.5倍,多管线获重大突破,显现巨大创新力 来源:格隆汇 8月31日,港股医药公司和铂医药发布中期业绩,报告显示其2022上半年,营收大增11.5倍,实现了跨越式的增长。 在行业景气度并不高涨的当下,和铂医药却能异军突起取得如此惊人的业绩增长,其中的深层次原因值得探究,或可借此进一步挖掘公司的长期价值。 多管线达成里程碑事件,丰富产品矩阵构建核心竞争力 作为新一代创新药企业的引领者,和铂医药以极快的速度研发出了一系列的创新药物。2017年时,公司仅有1项自主研发产品,但至2022年,公司已经拥有高达16项自主研发产品。和铂医药不仅拥有世界上稀缺的全人源重链抗体HCAb平台,更有全新的第二代全人源抗体发现平台H2L2,以及免疫细胞衔接器平台HBICE®。依托此三大技术平台,和铂医药已经形成了独具特色的创新而差异化的产品管线,管线内拥有多个全球首创和潜在同类最佳的优质自研资产。并且值得注意的是,公司的创新产品大多针对当前其他公司难以攻克的靶点和路径,开辟出了创新药的新时代。 值得注意的是,除了上述药物外,公司目前已有部分药物即将进入商业化阶段。进展最快的巴托利单抗(Batoclimab) HBM9161,预计2022年下半年/2023上半年就重症肌无力(MG)适应症提交BLA申请。 同时,针对干眼症的特那西普(Tanfanercept) HBM9036也已经完成了III期临床试验首次期中分析。 综合来看,和铂医药目前既有临近商业化阶段的药物,同时技术平台又不断研发出一系列差异化创新产品。全球授权的项目也接踵而至,可以判断,其营收将不断扩大,可持续造血能力将极大提升;另一方面随着潜力药物的临床推进加快,在收获期到来之时,公司将迎来管线的全面爆发,届时其价值将真正显现。 技术平台长期价值显现,实力获多方认可 进一步探究公司丰富管线的背后,可以发现和铂医药的技术平台在其中起着关键作用。从技术上来看,和铂医药的三大平台无疑是领先行业的,具体可以看到,全人源抗体发现平台H2L2,经典双重双轻链抗体技术平台,开发的产品安全性、成药性和亲和力均具有竞争优势。 全人源重链抗体发现平台HCAb则是和铂的独门绝技,其可产生全人源仅重链抗体,分子量小肿瘤穿透力性强,并可以有效解决双抗中的错配问题。 免疫细胞衔接器平台HBICE®则是公司发力特色双抗管线的关键,通过聚焦T细胞激活的“第一信号”和“第二信号”,将CD3双抗和4-1BB双抗齐头并进。 三大技术平台持续迭代升级,向多元化应用场景迈进,开发众多创新领域产品,由单抗到双抗、ADC、NK、Car-T等一系列前沿创新产品。优秀的平台也获得了市场的认可,从中报数据可以看到,公司报告期内营业收入达2760万美元,同比上升11.5倍。对于一家biotech企业而言,能取得这样的成绩实属亮眼。 深挖高营收背后的原因,可以看到,公司在过去的半年里,达成了多起商业合作。不仅与阿斯利康订立了一项最高交易金额达3.5亿美元的全球对外授权协议,更通过多元化创新合作商业模式,与多家跨国机构签订合作协议,包括在ADC方面与LegoChem和映恩生物达成项目合作。CAR-T方面与哈佛医学院附属医院Dana-Farber合作开发。和波士顿儿童医院合作开发创新性抗体疗法等。 上述合作都来自于公司技术平台及内部研发,尤其是与阿斯利康的合作,于临床前早期便完成了全球性的对外授权。相较于目前中国创新药企习惯于在临床阶段授权“出海”的做法,临床前授权需要药物发明者拥有更加扎实的早期研发能力,更为强大的专利技术壁垒以及更为充分早期数据验证。 反观阿斯利康能够在竞争激烈的CLDN18.2市场中选中HBM7022这一临床前资产,可见和铂医药在全球创新格局中独树一帜。同时,由于节约了庞大的临床试验开支,大大降低了开发成本,因此这次交易也能够为公司实现更加丰厚的投资价值回报。 除此外,公司还与恩凯赛药、华兰基因、百图生科、信达生物等多家机构达成合作,在NK细胞疗法、双抗、人工智能等领域进行探索和创新。 值得注意的是,和铂抗体平台的商业合作模式不仅限于纯粹的技术授权,同时还与其它产业创新引领者和学术机构,在下一代创新疗法上进行共同发现和共同开发。通过这样的模式,不仅能最大化平台的商业化价值,也能实现更高的创新效率。 目前,该平台已获得超过50个行业及学术界合作伙伴的认可。可以预见,基于和铂目前已经构建的合作范本,其抗体平台未来将有潜力,可以创造更多的收入,同时拓宽公司研发工作的范畴。 小结 随着我国创新药企研发实力的增强,很多创新药企业已经步入2.0阶段,逐渐与国际接轨,开始填补尚未满足的适应症空白,其议价能力也更强。这其中,那些布局开发难度较大的创新靶点的企业,以及高壁垒创新技术平台的企业,无疑是下一个十年最值得关注的企业。 在一众企业中,和铂医药已经显露了其价值,开发的产品已经产生了较好的营收,获得了国内外众多合作伙伴的认可。基于此优势,和铂医药后续在板块估值修复时,也大概率将是市场资金关注的焦点所在,有望享受市场给予的估值溢价,具备领跑行业的潜质。 文件: 和铂医药-B(02142.HK):营收大增11.5倍,多管线获重大突破,显现巨大创新力 2022-09-05 此新闻稿由EQS Group via SEAPRWire.com转载。本公告内容由发行人全权负责。原文链接: http://www.todayir.com/sc/index.php
More
Aggresive in Global Market Expansion, PIS Meets BP, Shell, and Exxon in Singapore ACN Newswire

Aggresive in Global Market Expansion, PIS Meets BP, Shell, and Exxon in Singapore

SINGAPORE, Sep 3, 2022 - (ACN Newswire via SEAPRWire.com) - Pertamina International Shipping (PIS) is increasingly targeting consumers in the international market. In addition to this expansion, PIS strives to continuously improve the quality and standard of service by exchanging knowledge and experiences with world energy companies.PT Pertamina International Shipping (PIS), in cooperation with PIS Pte Ltd (PIS PL), hosted a sharing session with BP Singapore Pte. Limited, Shell International Eastern Trading Co (SIETCO), and ExxonMobil Asia Pacific Pte Ltd. The meeting was held at the offices of each energy company on August 24-25, 2022, in Singapore.PIS, in cooperation with PIS Pte Ltd (PIS PL), hosted a sharing session with BP Singapore Pte. Limited, Shell International Eastern Trading Co (SIETCO), and ExxonMobil Asia Pacific Pte Ltd. The meeting was held at the offices of each energy company on August 24-25, 2022, in Singapore.During the sharing session, PIS discussed vetting, inspection, and vessel acceptance or vessel examination and inspection. The event was attended by PIS Director of Operations Arief Kurnia Risdianto, PIS PL Managing Director Brilian Perdana, Crude and Gas Operation (CGO) Vice President Harris Abdi Sembiring, and PIS Loss Prevention Safety Quality (LPSQ) Manager Soleh Komaruddin.BP Singapore Pte Ltd Vetting and Clearance Senior Manager, ExxonMobil Asia Pacific Pte Ltd Asia Pacific Supply Coordinator, ExxonMobil Asia Pacific Pte Ltd Mogas Lead, ExxonMobil Asia Pacific Pte Ltd Global Senior Marine Operations, SIETCO Mogas Operation Team Lead, SIETCO Head of Marine, SIETCO Senior Originator, and more were also in attendance at this meeting.The meeting was also a PIS endeavor to escalate acceptance of its ships at the terminals of world energy participants such as BP, Shell, and Exxon to showcase the existence and quality of PIS in international settings. In the maritime and energy sectors, these companies are significant participants that dominate the tanker chartering market called the Seven Sisters.PIS Director of Operations, Arief Kurnia Risdianto, explained PIS performance which has now explored 12 international routes. PIS ships have met international shipping standards, including the Paris MOU for sailing requirements on the European continent and a Certificate of Compliance from the United States Coast Guard (USCG)."PIS is the largest tanker operator in Southeast Asia, currently operating around 439 vessels with extensive experience serving the domestic and regional market," he said.Experience of PIS in serving the regional market is recorded by many international customers, including Vitol, Petronas, Trafigura, BP, Badak LNG, ExxonMobil, Petrobras, Chevron, Saudi Aramco, Shell, and many more.As the Integrated Marine Logistics Sub Holding of PT Pertamina (Persero), PIS business includes shipping, marine services, port services, port and jetty management (port ownership), storage tanks, and other related services.PIS owns two VLCCs, namely, Pertamina Pride and Pertamina Prime, with a capacity of 2 million barrels and incurs the Eco-Green Vessel concept. The two VLCCs are tangible manifestations of PIS endeavor to lead the marine and logistics business in both domestic and international markets.Besides oil and gas, PIS expands its business potential to various segments and cargo types, including petrochemicals with medium-range chemical-specific vessel assets called PIS Precious.In the meantime, to comply with regional trading and improve its role in the global market, Tanjung Uban offers an integrated terminal managed by the PIS subsidiary.PIS CEO Erry Widiastono said that the company has prepared a roadmap to support energy transition programs. "PIS will anticipate the future of vessels business, specifically the greener vessels. For example, vessels responsible for gas shipping such as LPG, LNG, and many others. In the future, we will anticipate the progress of the renewable energy sector," said Erry.About Pertamina International Shipping (PIS)As the Integrated Marine Logistics Sub Holding, PT Pertamina International Shipping (PIS) consistently stimulates Indonesia's economic growth through safe and sustainable operation, becomes a trusted and reliable maritime partner, and promotes value for the stakeholders in running their business. See https://pertamina-pis.com/. Media Contact:M Aryomekka FirdausCorporate SecretaryM: +62-811-872-272E: aryomekka@pertamina.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
The Growhub Innovations Company Announces Joint Project with Koufuku Group to Explore Asean Market Penetration ACN Newswire

The Growhub Innovations Company Announces Joint Project with Koufuku Group to Explore Asean Market Penetration

SINGAPORE, Sep 3, 2022 - (ACN Newswire via SEAPRWire.com) - The GrowHub Innovations Company ("The GrowHub"), Asia Pacific's only Web3-enabled plug-and-play ecosystem builder for food traceability and carbon credits, and KOUFUKU GROUP, a Japanese food company with over 50 years of history, have signed an MoU partnership for a joint project on market penetration using The GrowHub's proprietary Web3 technology.This partnership will further enhance Japan's food traceability for Japanese consumers by enabling access to blockchain-driven technology solutions. The GrowHub's Web3 technology provides food manufacturers with an evidence-based understanding of the conditions necessary for market penetration of their products in the ASEAN market. In addition, GrowHub can also help food companies meet market penetration requirements.Dr. Daiki Nakaoka, the Country Head of GrowHub Japan, said, "The ASEAN market, which is expected to grow significantly, is attractive to many food manufacturers. However, the question and challenge of whether and how to gain acceptance of their products in that market is always a hurdle that is not low for food manufacturers to expand. This project would be one example that GrowHub's unique Web3 technology demonstrates it can answer such questions to the food manufacturers and help them solve such challenges.To ensure safety, provenance and traceability, GrowHub uses a proprietary blockchain-enabled technology platform that provides rich data-driven insights to agrifood producers and third-party solution providers by allowing partners to integrate directly into an existing system through GrowHub APIs. The information recorded on the blockchain is secure and non-reversible giving true transparency to the ecosystem.About The GrowHub Innovations CompanyThe GrowHub Innovations Company ( www.thegrowhub.co ) is Asia Pacific's only Web 3-enabled technology plug-and-play ecosystem builder focusing on food traceability and carbon credits. The GrowHub has strong and exclusive relations with the government bodies in Western Australia and Singapore - Food Innovation Precinct Western Australia (FIPWA) and PEEL Development, Shire of Murray. Currently in eight markets across Australia and Asia Pacific, The GrowHub offers access to trusted premium products at affordable rates through the development of new agri-food and blockchain technologies emerging from our innovation centre at FIPWA. With the capital, network and expertise, we use technology to improve the experience of "farm-to-fork". From crunching data to enable producers to improve yields, to leveraging statistics to enable better transportation of produce, to the information on the quality of food you pay for at the table, our blockchain technology allows for full food traceability across the supply chain - so that you can trust in the food you eat.About KOUFUKU GROUPKOUFUKU GROUP was founded in 1968 as a rice shop and has been supporting food, beauty, and health in Japan for more than 50 years. Amidst growing social awareness of food safety and security, we have been aiming to create new value as a manufacturer that consistently provides delicious and safe food products, supports consumers' eating habits, and maximizes the any further potential of food products. Furthermore, we also engages in businesses that focus on the happiness and future of people by developing high-quality health and beauty products and researching biomass for the beauty and health as well as the creation of a sustainable society. Under the corporate identity of "Science Materials and Create Happiness," our business activities aim to realize a sustainable society, an extension of healthy life expectancy, a beautiful and glowing lifestyle, a safe and renewable food distribution, and carbon neutrality by the year 2030. To find out more about GrowHub please visit: https://thegrowhub.co/For Media Enquires, Please Contact:PRecious Communications for GrowHub growhub@preciouscomms.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
Pertamina saves US$402.46 million amid rising global oil prices ACN Newswire

Pertamina saves US$402.46 million amid rising global oil prices

JAKARTA, Sep 3, 2022 - (ACN Newswire via SEAPRWire.com) - State-owned oil and gas company PT Pertamina succeeded in saving operational costs of around Rp6 trillion (US$402.46 million) until July 2022 through several efficiency programs amid rising world oil prices that increased fuel production costs.PT Pertamina head office building (ANTARA/HO-PT Pertamina)She explained that energy companies around the world are facing difficult situations as a result of disruption of the global energy supply chain due to the Russia-Ukraine conflict. The global trade mobility leading to post-pandemic recovery was jolted by limited supply that led to an energy crisis.The president director noted that the Indonesian government's policy of maintaining the people's purchasing power through fuel subsidies was the proper measure to accelerate economic recovery.According to Widyawati, the accuracy of the policy is reflected in the fuel consumption increase for community mobility and business activities.Pertamina President Director Nicke Widyawati stated that such a success could not be separated from strategic cost-saving measures taken by the company group since the start of this year.She explained that energy companies around the world are facing difficult situations as a result of disruption of the global energy supply chain due to the Russia-Ukraine conflict. The global trade mobility leading to post-pandemic recovery was jolted by limited supply that led to an energy crisis.The president director noted that the Indonesian government's policy of maintaining the people's purchasing power through fuel subsidies was the proper measure to accelerate economic recovery.According to Widyawati, the accuracy of the policy is reflected in the fuel consumption increase for community mobility and business activities.On the other hand, she also pointed out that the increase in fuel consumption had caused an increase in the burden of government subsidies."We understand the heavy burden of the government's fuel subsidy, and for that Pertamina carries out various cost-saving programs in order to help reduce the burden," she stated.She remarked that the largest chunk of the company's cost of fuel production is for the purchase of crude oil, which accounts for 92 percent of the production costs.Fortunately, investment in upgrading the Pertamina Oil Refinery, which had been conducted in the last four years, had succeeded in increasing the flexibility of crude oil availability.It means, if so far, the Pertamina refinery has only been able to process certain crude oil that is expensive, but starting last year, it has been able to process crude oil, with a higher sulfur content, which is cheaper and can be gained from many sources," Widyawati stated.This is Pertamina's strategic move that has succeeded in significantly reducing fuel production costs, she affirmed.In addition, the company's energy efficiency efforts in all operational areas -- from upstream to downstream -- had caused significant cost savings while also contributing to a reduction in carbon emissions."The post-restructuring breakthrough, which is also significant to achieve Pertamina Group's efficiency, is the centralization of the procurement of goods and services, as well as the integration and optimization of all assets from upstream to downstream," she stated.Apart from saving costs, the Pertamina Group has also succeeded in increasing its revenue through the export of high value-added products, such as HVO (palm-based D100) and Low Sulfur Fuel Oil.By upgrading its refineries, Pertamina has currently been able to produce more low-carbon products whose demand had continued to increase, thereby capturing a very prospective opportunity in the midst of global demand for such a product."For Pertamina, cost savings are not just about cutting costs but also changing operating models and improving business processes, so that all company programs can be carried out and all targets are achieved, but at a lower cost," Widyawati stated."Pertamina will continue to make various efforts to save costs, which at the same time can reduce carbon emissions, thereby supporting the company's and national energy transition efforts," she said.Contact: Fajriyah Usman, VP Corporate Communications, PT Pertamina (Persero)M: +62 858 8330 8686, Email: fajriyah.usman@pertamina.com, URL: https://www.pertamina.comWritten by: Yuni Arisandy Sinaga, Editor: Rahmad Nasution (c) ANTARA 2022 Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
G20 Digital Ministers yields consensus on 3 priorities ACN Newswire

G20 Digital Ministers yields consensus on 3 priorities

JAKARTA, Sep 3, 2022 - (ACN Newswire via SEAPRWire.com) - The Digital Economy Ministers Meeting (DEMM) was held in Nusa Dua, Bali, Thursday (September 1, 2022). It was the culmination of the Digital Economy Working Group (DEWG) meetings, as one of working group of the G20 that focuses on issues related to the digital economy and highlights the role of digital transformation on economic and social growth. Communication and Information Minister Johnny G. Plate opened the 2022 G20 Digital Economy Ministers' Meeting in Nusa Dua, Bali province, on Thursday (September 1, 2022). (ANTARA PHOTO/Hafidz Mubarak A/foc/uyu)The DEWG itself discussed three priority issues of the digital economy at the G20 Indonesia Presidency, including digital connectivity, digital skills and literacy, and cross-country data flow.The Minister of Communication and Informatics, Johnny G. Plate, said the DEMM has produced a document called "G20 Digital Economy Minister Meetings 2022; Chair Summary".The document summarizes agreements between the ministers for the digital economy on the three priority issues of the DEWG. "The document shows that for all substantive content, the Indonesian Presidency (G20) has reached consensus from all DEWG members in accordance with DEWG priority issues," Plate said at a press conference, Thursday afternoon. It also summarizes all ideas and dynamics that developed during the series of G20 DEWG meetings presented by representatives of G20 member countries over the past six months. The formulation of concrete steps in the document will be presented as input for President Joko Widodo in leading the G20 Summit which will be held in November.On the first priority issue regarding connectivity and post-COVID-19 recovery, Plate said the meeting agreed on the need for a people center in an effort to strengthen digital connectivity. The meeting, he said, also agreed on the importance of digital security as the key to business sustainability. "The meeting also welcomed various initiatives of the G20 Indonesia Presidency, such as the G20 Digital Innovation Network (DIN), G20 Digital Transformation Expo (DTE), and the smart village and island initiative together with ITU," he said. On the issue of digital skills and digital literacy which is the second priority issue, the DEMM meeting succeeded in compiling the "G20 toolkit for measuring digital skills and digital literacy". The document is useful for standardizing the measurement of literacy indicators and digital skills for more objective public policy making and encouraging international cooperation in overcoming gaps between countries, responding to the challenges of a digital future. "The presidency has also succeeded in compiling a compilation of reports on policies and recommendations to increase meaningful participation of vulnerable groups in the digital economy, as well as a summary document of practices and policies on digital skills and advanced digital literacy," he said. On the issue of free data flow with trust and cross-border data flow, Johnny said the DEWG forum has recognized the efforts of the Indonesian Presidency to initiate discussions on the principles of justice, transparency and legitimacy proposed by Indonesia. "This is a new principle base in cross-border data governance. We all know that data contains at least two important things. The first is that the data has a high economic value, and the second is that the data is related to geopolitics and geostrategy as well as the sovereignty of each nation and state," he explained. The DEMM meeting was attended by digital ministers from the United Arab Emirates (UAE), Singapore, Cambodia, South Africa, Japan, India, Saudi Arabia, the United Kingdom, and the Netherlands. Meanwhile, Australia, Germany and Spain were represented by ministerial representatives. DEMM was also attended by representatives from international organizations, including the Secretary General of the International Telecommunication Union (ITU) and the Under Secretary General of the United Nations and Executive Secretary of the United Nations Economic and Social Commission for Asia and The Pacific (UNESCAP).Written by: Rizka Khaerunnisa, Uyu Liman, Editor: Suharto (c) ANTARA 2022 Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
亚太地区吸引了50%的全球临床试验 根据新的GlobalData报告 ACN Newswire

亚太地区吸引了50%的全球临床试验 根据新的GlobalData报告

SYDNEY, Sep 2, 2022 - (亚太商讯 via SEAPRWire.com) - 亚太地区领先的生物技术临床研究机构 Novotech 在一份题为“亚太地区临床试验的演变”的报告中发布了新的市场数据。 该报告由 GlobalData 编写,并确认“亚太地区 (APAC) 地区是 2017 年至 2021 年全球临床试验格局的最大贡献者,占分析期间进行的试验的 50% 以上。”点击下载报告 https://novotech-cro.com/whitepapers/evolution-clinical-trials-asia-pacific-region-compared-us-and-eu5此外,GlobalData 研究发现,该地区所有临床试验阶段的增长均高于美国和欧盟5。在中枢神经系统疾病、心血管疾病、胃肠道疾病和传染病等所有分析治疗领域,该地区的增长率均显着高于美国和欧盟五国,其中后者的增长率最高。 同期肿瘤学试验也有 100% 的增长。GlobalData 对这一强劲增长的分析与一系列因素有关,包括:- 与美国和欧洲相比,站点可用性——尤其是肿瘤学试验- 降低运营成本- 亚洲人群的药物基因组学特征是需要当地人群 I 期数据的关键因素。GlobalData 表示:“再加上监管合规的便利性和所需的高标准,海外制药商从未如此热衷于进入这个新兴市场。最近在国家卫生健康委员会(NHC)和国家药品监督管理局(NMPA)的指导下,政府简化了药品审批流程,也导致了基于全球标准的更高效、更清晰的药品审批系统。”据 Novotech 全球临床服务副总裁 Yooni Kim 所说:“亚太地区以其庞大的患者群体、竞争力较弱的临床试验环境和世界级的 KOL 为加快临床试验提供了一个令人信服的解决方案,此外,监管改革加快了审批流程。Novotech 的服务交付模式是根据生物技术客户的需求量身定制的。我们的本地团队拥有卓越的现场和研究人员访问权限,我们的项目管理方法强调解决问题、所有权和灵活性,我们对数据和技术的投资确保客户能够实时访问试验绩效。此外,亚太地区和美国经验丰富的 CRO 业务为早期至晚期生物技术临床研究提供了一套独特且无与伦比的服务。”Novotech 最近被评为全球领先的 CRO 中的前 10 名 CRO,并在过去 3 年中签署了 45 份领先的网站合作协议。关于Novotech健康控股Novotech健康控股有限公司(“Novotech”)是亚太地区及美国领先的生物技术专家 CRO。 Novotech 是一家 CRO,拥有综合实验室和 I 期设施,提供药物开发咨询和临床开发服务。它有助于在所有试验阶段和广泛的治疗领域成功进行大约 4,000 项临床试验。Novotech具有明显优势,可以为在亚洲及美国进行临床试验的生物制药客户提供服务。详细信息请访问 https://novotech-cro.com/contact媒体联系人David JamesE: communications@novotech-cro.com澳大利亚: +61 2 8218 2144美国: +1 415 951 3228亚洲: +65 3159 3427 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More

Jefferies maintains Buy rating on Yeahka(09923.HK)

HONG KONG, Sep 2, 2022 - (ACN Newswire via SEAPRWire.com) - Yeahka, the leading payment-based technology platform in China announced its 2022 interim results in late August. During the period, total revenue climbed 17.1% to RMB1,641.8 million, gross profit rose 52.1% to RMB529.3 million, and gross margin increased from 24.8% to 32.2%."Yeahka's 1H revenue and adjusted EBITDA beat our estimates. Management highlighted multi-channels strategies to embrace in-store e-commerce opportunities and reaffirmed full-year GMV guidance. We expect it to maintain fast growth trend in 2023 due to the huge addressable market ahead. We revise our payment volume assumptions in 2H due to the recent resurgence of the pandemic and estimate take-rate to be better than expected for the full year." Jefferies says in its newly released research report.Jefferies emphasizes that Yeahka is one of the 16 payment service providers with a national bank card acquiring license and mobile phone payment license from the PBOC, which currently has 7.3m active payment service merchants. The payment business provides traffic, merchants and data insights to Yeahka, in particular payment and online marketing services. Backed by its merchants and consumer networks in payment, Yeahka adds value to merchants through SaaS products in digitization, online marketing through DSP platform and fintech services.According to the report, Jefferies maintains its Buy rating with PT of HKD21 on Yeahka based on PEG. It applies a 10% discount to PEG due to uncertainties of macro headwinds and pandemic outbreak, factoring in the recent business developments with a focus on GPV and customer growth, while the support to merchants and investments in new initiatives are important for the long term. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
医思健康主席邓志辉增持公司股份 对集团业务未来发展态势维持信心 ACN Newswire

医思健康主席邓志辉增持公司股份 对集团业务未来发展态势维持信心

HONG KONG, Sep 2, 2022 - (亚太商讯 via SEAPRWire.com) - 香港最大非医院医疗服务机构* ── 医思健康(「公司」,连同附属公司,总称「集团」;香港联交所股份编号:2138)欣然宣布,集团主席、行政总裁及执行董事邓志辉先生(「邓先生」)于2022年 9月1日于公开市场新增购入107,000股,涉资约58.7万港元,每股股份平均价格约5.4905港元。是次进一步增持完成后,邓先生持有的股份数为722,034,610股,持股比例由61.26%增至61.27%。医思健康主席、执行董事兼行政总裁邓志辉先生表示︰「受益于集团对资讯科技,服务,品牌的持续性投入,集团2023财年第一季度(2022年4-6月)录得不少于8.6亿港元的销售额,业务展现良好恢复态势。医思健康将持续通过内生增长和外延并购进行大健康市场的整合,巩固市场领先地位。集团相信医疗市场在充满挑战的经营环境下将总体维持韧性,且长期而言公营及民营医疗健康领域的合作将推动香港民营医疗市场的支出不断增加。展望未来,管理层对集团业务表现持乐观态度,集团亦将持续推进与科技,电讯,房地产,保险及制药领域巨头的深度合作以不断完善医思闭环大健康生态系统。」关于医思健康香港最大非医院医疗服务供应商*医思健康以预防及精准医疗为业务核心,透过多元服务整合发展医疗人工智慧,配套高端品牌及优质客户服务,致力为客户提供最专业、安全、有效的医疗健康服务。 集团目前直营的诊所/服务中心主要位于大湾区,提供一站式医疗及健康服务。服务涵盖面极广,旗下主要知名服务品牌包括连续多年荣膺全港第一的一站式医学美容解决方案DR REBORN,及多元化多维度的医学服务包括:普通科门诊企鹅杏仁、脊骨神经关节痛症全科中心、纽约脊骨物理治疗中心、健康管理中心香港仁和体检中心、疫苗中心香港安苗医疗中心、全方位牙科服务中心EC DENTALCARE、诊断影像中心博思医学诊断中心、仁生肿瘤及癌症中心、内视镜及日间医疗中心仁辉专科中心、专科中心联汇专科,新医疗中心及进汇医务中心、心脏专科香港国际心脏专科中心、儿科专科汇儿儿科医务中心、妇产科专科卓越医务中心及产前诊断中心、柏立医学化验所、专业健发中心发森、眼科中心唯视眼科和医思兽医医院及影像中心。*根据弗若斯特沙利文公司按2020年及2021年收入计算进行的独立研究若有进一步垂询,请联络:iPR奥美公关刘丽恩 / 陆咏诗 / 叶子欣电话:(852) 2136 6952 / 2169 0467 / 3920 7649传真:(852) 3170 6606电邮:ech@iprogilvy.com Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
TOYOTA GAZOO Racing going for gold in Greece JCN Newswire

TOYOTA GAZOO Racing going for gold in Greece

TOKYO, Sep 2, 2022 - (JCN Newswire via SEAPRWire.com) - The TOYOTA GAZOO Racing World Rally Team aims to return to the top step of the podium on the legendary Acropolis Rally in Greece on September 8-11, round 10 of the 2022 FIA World Rally Championship.2022 GR YARIS Rally1 HYBRIDMap Acropolis Rally Greece 2022The Acropolis returned to the WRC calendar in 2021, having been an almost permanent fixture up until 2013 with a reputation for rocky mountain roads and high temperatures which combine to create a tough challenge for the cars, tyres and drivers.Kalle Rovanpera, who won the event at the first attempt last year, has a lead of 72 points with four rounds remaining and the possibility to write his name in history in Greece if he can finish the rally on the podium, depending on others' results.After finishing second last time out in Belgium, Elfyn Evans is third in the standings and one of those also still in contention for the drivers' title. Following two podiums in the last two rounds, Esapekka Lappi will contest the Acropolis for the first time since 2014, while Takamoto Katsuta will make his event debut with TGR WRT Next Generation.This year's rally begins with a Thursday night superspecial stage in the Athens Olympic Stadium, which previously hosted the WRC in 2005/06. From there crews head directly west to Loutraki, ready for two passes of the stage of the same name on Friday morning, sandwiching a single pass of the adjacent Harvati. The afternoon journey north to the service park in Lamia includes three more stages: a tyre-fitting zone separates the new Dafni and Livadia tests, which are followed by Bauxites. Saturday consists of two loops of three stages west of Lamia and almost half of the rally's competitive distance. Pyrgos is the longest stage of the weekend at 33.2 kilometres and precedes the returning Perivoli and famous Tarzan test. On Sunday, Elatia-Rengini separates two passes of Eleftherohori, the second forming the rally-ending Power Stage.Quotes:Jari-Matti Latvala (Team Principal)"After being very close to the victory in the last two rallies, we go to Greece really wanting to win, but we know that it won't be easy on such a tough event. The Acropolis is a legendary rally and it's great to have it back on the calendar since last year. We saw that the gravel roads there are generally not quite as rough as they were in the past. This means that, although reliability is still really important, we also need to have a strong level of performance. Kalle took a great victory last year in difficult conditions and rain which is of course not typical in Greece. Repeating that will be difficult now he is running first on the road, especially as most of Friday's stages are run only once, but Kalle has been handling this challenge very well so far this season. Elfyn and Esapekka have also been very strong recently and hopefully they can continue in a similar way in Greece."Elfyn Evans (Driver car 33)"I'm looking forward to the Acropolis Rally. After the high-speed nature of Estonia and Finland, Greece will offer a very different challenge for a gravel rally. Sardinia was the last rough gravel event we had in Europe and we had quite a good feeling with the car there and good speed, even though we didn't get the result at the end of the weekend. There are still things we can improve, and hopefully we can pick up where we left off and keep making steps forward in Greece. Most likely it will be a hot and tough rally like the Acropolis is known for, but we saw last year with the rain that we can't be completely certain about the weather."Kalle Rovanpera (Driver car 69)"Belgium was a difficult weekend for us, so in Greece we just need to get back at the level where we should be and try to have a good rally. The championship is never over until it's over so we can't think about it too much: We're just trying to get good points from each event and control what we can. Greece was a really nice rally for us last year but our chances this time will probably depend a lot on the weather. If it's going to be dry then I think it's going to be really tricky for us to open the road on Friday. If so, it probably won't be much easier for our rivals just behind us, and hopefully we can still make the best of the situation."Esapekka Lappi (Driver car 4)"In Greece we will be going to something that's quite unknown for me. I did the rally once before in 2014 when it was a round of the European championship, but half of it was on asphalt then, so there will be a lot that's new to discover. But I had also not been to Ypres for eight years and we finished on the podium there. So we will try and aim for something similar again this time. We had good speed and a good feeling on similarly rough gravel roads in Sardinia, and hopefully we can find that again in Greece."Please visit www.wrc.com for the latest. Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)
More
MHI Finalizes Terms of First Transition Bond Issuance JCN Newswire

MHI Finalizes Terms of First Transition Bond Issuance

TOKYO, Sep 2, 2022 - (JCN Newswire via SEAPRWire.com) - Mitsubishi Heavy Industries, Ltd. (MHI) has finalized the issuance terms of the transition bond being issued today via public offering in the domestic market, as announced in the Company's press release of August 5, 2022.The issuance is based on MHI's selection as a model example for the "2021 Climate Transition Finance Model Projects"* being supported by the Ministry of Economy, Trade and Industry (METI), as announced in the Company's press release of March 18, 2022. One of the unique features of this model example is that MHI not only plans to achieve emission reductions from its own economic activities, but will also attempt to enable the realization of transition strategies of other parties through its products and services.Through issuance of its first transition bond, MHI looks to diversify its fund procurement methods and achieve its target of carbon neutrality by 2040.*Projects supported by METI which provide information on and reduce the assessment costs of examples that are deemed to have model qualities for promoting the spread of transition finance. Examples that conform to the "Basic Guidelines on Climate Transition Finance," formulated by the Ministry of the Environment (MOE) and the Financial Services Agency (FSA), and have model qualities are selected as model examples. For further information: bit.ly/3RgPNh5About MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world's leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)
More
WIKA Books Sales of Rp7.18 Trillion in Q2-2022 ACN Newswire

WIKA Books Sales of Rp7.18 Trillion in Q2-2022

JAKARTA, Sep 2, 2022 - (ACN Newswire via SEAPRWire.com) - PT WIJAYA KARYA (Persero) Tbk. [IDX: WIKA] successfully booked a gross profit of Rp627.24 billion in Q2-2022 or 14.8% higher on a year-on-year basis (YoY) as recorded in the financial statement for the period ended on 30 June 2022. This figure was supported by the Company's sales of Rp7.18 trillion or 6.2% higher YoY.WIKA's President Director, Agung Budi Waskito (Agung BW) said the improvement in sales performance was enabled by a 2% increase in infrastructure and building sector, 9.8% increase in industry sector, and 167.6% increase in realty & property sector YoY. Most of the revenue in realty & property sector was contributed by the hotel business as a result of the State-owned Enterprises or BUMN hotel holding process by WIKA's subsidiary, WIKA Realty.As at July, WIKA has secured new contracts worth Rp14.67 trillion. The largest contributors were the infrastructure and building sector of 58.4% and the industry sector of 22.7%. The high number of new contracts in these sectors is also due to the strategic infrastructure development program that is being promoted by the Indonesian Government to face the G20.PT WIJAYA KARYA (Persero) Tbk. [IDX: WIKA]Contact:Mahendra VijayaSekretaris PerusahaanEmail: mahendra.v@wikamail.id Website: https://www.wika.co.id/ Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More

Younger Colorectal Cancer Population Highlights the Importance of Early Screening, Highly Sensitive Test Product Prenetics has Launched the Market

HONG KONG, Sep 2, 2022 - (ACN Newswire via SEAPRWire.com) - Colorectal cancer (CRC) has become one of the main cancers threatening the health of human beings. In the United States and China, CRC has ranked among the top three cancers that leads to death.CRC screening has been proven to be one of the most effective tools for preventing colorectal cancer. Research indicated that since screening was first recommended in 1980 in the United States, the incidence rate of CRC has dropped by 40%. Meanwhile, it's also important to follow the updated evidence, ensuring that the screening is suitable for the people who benefit most.The onset of Disease Tends to be YoungerLatest research has indicated that 94% of newly CRC cases occur in adults over 45 years old. Among which, the number of newly onset and death cases occurring in individuals under the age of 50 has increased a lot. CRC diagnosis among younger adults is growing.Therefore, National Comprehensive Cancer Network (NCCN) has updated its guidance in 2021, suggesting that people at average risk shall conduct screening from the age of 45.U.S. Preventive Services Task Force (USPSTF) also pointed out that all asymptomatic adults aged 45 years old or above are exposed to CRC risks. Even without high-risk factors, they're recommended to take CRC screening.Although the incidence rate of CRC is as high as thyroid cancer and breast cancer, chance of treating CRC is better at an early age. It is very important to early find and treat the disease to ensure a higher survival rate. Research by the world-leading diagnosis and genetic health testing company Prenetics (PRE.O) showed that the 5-year survival rate of stage I and II CRC is up to 90% and stage III is 72.8%. It falls to 15.1% for stage IV CRC.Despite the significantly higher survival rate in the early treatment of CRC, unfortunately nearly half of the CRC cases are detected in the advanced stage, leading to extremely difficult treatment. Lacking a convenient and highly effective detection method is the vital cause of this phenomenon.Significant Reform of CRC DetectionCRC screening has always relied on invasive detection methods including colonoscopy. Since such detection may cause pain or discomfort, some patients refuse the screening.With the rising popularity of genetic detection science, CRC screening has welcomed a significant reform. Currently, a non-invasive and at-home screening test product - ColoClear has been introduced by Prenetics and New Horizon Health to the Southeast Asia market, which can detect pre-cancerous lesions and early, middle, and advanced stage CRC in an effective way.Combining advanced stool DNA technology with a fecal immunochemical test (FIT), ColoClear is easier, cheaper, and simpler and has high sensitivity, up to 96%, which is comparable to the traditional colonoscopy.On top of ColoClear, CircleDNA, a home health diagnosis product of Prenetics that give over 500 test reports in 20 categories, which plays an important role in the early detection of cancer and other potential disease risks. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report ACN Newswire

APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report

SYDNEY, Sep 2, 2022 - (ACN Newswire via SEAPRWire.com) - Novotech, the leading Asia Pacific biotech specialist CRO has released new market data in a report now available titled "Evolution of Clinical Trials in the Asia Pacific Region". The report was prepared by GlobalData and confirms that "the Asia-Pacific (APAC) region was the largest contributor to the global clinical trial landscape from 2017 to 2021, accounting for more than 50% of conducted trials during the analysis period."Download report here https://novotech-cro.com/whitepapers/evolution-clinical-trials-asia-pacific-region-compared-us-and-eu5In addition, the GlobalData research found that all phases of clinical trials in the region registered higher growth than both the US and the EU5.The region registered significantly higher growth than the US and the EU5 across all analysed therapeutic areas, including CNS diseases, cardiovascular diseases, gastrointestinal diseases, and infectious diseases, the latter of which witnessed the highest growth. There was also 100% growth in oncology trials during the same period.GlobalData analysis of this strong growth has been linked to a range of factors, including:- site availability, particularly for oncology trials, when compared to the US and Europe- lower operating costs- the pharmacogenomic profile of Asian populations as a key factor that requires Phase I data in local populations. "Add to the mix the ease of regulatory compliance as well as the high standards required, and overseas drugmakers have never been keener to access this burgeoning market," according to GlobalData. "Recent streamlining of drug approval by the government, guided by the National Health Commission (NHC) and National Medical Products Administration (NMPA), has also resulted in a more efficient and clear-cut drug approval system based on global standards."According to Yooni Kim, Vice President, Global Clinical Services Novotech: "Asia-Pacific offers a compelling solution for expedited clinical trials with its vast patient populations, less competitive clinical trial landscape, and world-class KOLs, in addition, regulatory reforms have accelerated approval processes. Novotech's service delivery model is tailored to the needs of biotech clients. Our local teams have exceptional site and investigator access, our project management approach emphasizes problem-solving, ownership and flexibility, and our investments in data and technology ensure clients have real-time access to trial performance. In addition, experienced CRO operations across APAC and the US offer a unique and unparalleled suite of services for early to late phase biotech clinical research."Novotech has recently been benchmarked as a top 10 CRO among the world's leading CROs, and has signed 45 Leading Site Partnership agreements over the last 3 years. About Novotech Novotech is the leading Asia-Pacific biotech specialist CRO. Novotech has integrated labs and phase I facilities and provides drug development consulting and clinical development services across all phases. It has been instrumental in the success of approximately 4,000 clinical trials across a broad range of therapeutic areas. Novotech is well-positioned to serve biopharma clients conducting clinical trials in Asia-Pacific and the US. For more information visit https://novotech-cro.com/contactMedia ContactDavid JamesE: communications@novotech-cro.comAU: +61 2 8218 2144 USA: +1 415 951 3228Asia: +65 3159 3427 Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
Leading VC Firm, Black3Lab Capital Announces Investment in Ripe Web 3.0 Sectors SeaPRwire

Leading VC Firm, Black3Lab Capital Announces Investment in Ripe Web 3.0 Sectors

New York, NY, September 02, 2022 – (SEAPRWire) – Black3Lab Capital, a venture capital firm built to empower web 3.0 companies with potential for global mass adoption, has announced investments in ripe web 3.0 sectors. Black3Lab’s proposed $50 to $100 million fund will focus on building a genuinely feasible economy of web 3.0-fueled products and services for the global populace. In addition to investing in potentially productive web 3.0 sectors, Black3Lab will undertake the enterprise adoption of social media, gaming, and NFTs. At a recently concluded launch ceremony, co-founder of Black3Lab, Alex Chong, announced that the putative investment fund is in partnership with three famous partners. The Black3Lab fund will focus primarily on enriching projects with the potential to accelerate global adoption. “We are hyper-focused on web 3.0 companies with the suitable DNA to integrate with existing conglomerates with millions of customers for Black3Lab portfolio companies to tap. Ultimately, mass user adoption will allow web 3.0 platforms and projects to achieve explosive growth and sustainable revenue generation capabilities,” Alex Chong reveals. Unlike web 2.0, which gave rise to internet giants like Google, Apple, Facebook, etc., web 3.0 promotes user-centric ownership, harmonizing perfectly with human incentives. Speaking about the current web 2.0 internet phase and the rise of centralized tech giants, the co-founder of Black3Lab reiterated Alex Chong’s claims of web 3.0’s potential to deliver at least ten times the market opportunities of the former. “User-centric networks deliver significantly higher and more explosive growth than their centralized competitors. At the core, you can always find more favorable terms for users. Web 2.0 gave birth to a US$10 trillion market, and now web 3.0 has the potential to deliver ten times the market opportunities,” Candy states. The Black3Lab fund will incorporate a dynamic trading strategy that delivers consistent returns of over 30% to investors. Black3Lab Partners Per Alex Chong’s announcement at the launch ceremony held at the Peninsula Hotel, Hong Kong, on 18th August 2022, Black3Lab has partnered with notable media veterans like Bob. Bob led the global collaboration team of some of the biggest media tech companies. He also led Strategies and Partnerships at Forkast—a web 3.0 media ecosystem. Bob recapitulates Candy’s idea of user-centric ownership as the key to driving mass adoption in the emerging web 3.0 space. “Black3Lab Capital is notably unique: We exist not just out of the goal for strong financial returns but to foster the mass adoption of web 3.0 solutions. We believe user-centric ownership will be the key to unleashing the next-generation internet,” Bob says. About Black3Lab Capital Black3Lab Capital is a VC firm founded in Hong Kong. Black3Lab aims to empower web 3.0 companies with maximum potential for accelerated mass success, offering high returns to investors. The team comprises renowned enterprise founders, tech developers, VCs, media executives, and F&B entrepreneurs keen on introducing a more equitable, rewarding, and innovative internet economy. Social Contact Instagram: https://www.instagram.com/black3lab/ Media Contact Brand: Black3Lab Capital Contact: Alex Chong, Co-founder & Partner Email: info@black3lab.com Website: https://www.black3lab.com/ PR provider: https://finpr.agency SOURCE: Black3Lab Capital The article is provided by a third-party content provider. SEAPRWire ( https://www.seaprwire.com/ ) makes no warranties or representations in connection therewith. Any questions, please contact cs/at/SEAPRWire.com Sectors: Top Story, Daily News SEA PRWire: PR distribution in Southeast Asia (Hong Kong: AsiaExcite, EastMud; AsiaEase; Singapore: SEAChronicle, VOASG; NetDace; Thailand: SEAsiabiz, AccessTH; Indonesia: SEATribune, DailyBerita; Philippines: SEATickers, PHNotes; Malaysia: SEANewswire, KULPR; Vietnam: SEANewsDesk, PostVN)
More

百奥赛图今日登陆港交所 硬核技术打通新药研发全链条

HONG KONG, Sep 2, 2022 - (亚太商讯 via SEAPRWire.com) - 近年来,随着人口老龄化程度加深及慢性病人数的不断增长,社会对医疗保健的需求不断增加,在中国政府鼓励创新的系列政策支持下,底层创新生物医药领域已成为资本市场公认的风口。今日,作为临床阶段生物技术及临床前研究服务创收公司,百奥赛图正式登陆港交所主板,股份代号:02315.HK,由高盛与中金公司联席保荐。据悉,百奥赛图以专有基因编辑技术、转基因小鼠平台、综合动物病患模型及高通量体内抗体发现平台为依托,经过多年的发展,已经建立涵盖早期靶点认证及抗体生成到临床开发的全链条综合研发实力。硬核技术加持 底层创新能力助力多元服务创收根据招股书,百奥赛图依托自主研发的ESC/HR、EGE系统和SUPCE三大基因编辑核心技术,近乎实现任意长度、任意位点的精确基因组编辑,处于国际领先水平。公司不仅通过基因编辑服务获得商业回报,亦在此基础上开发了专有全人抗体RenMice平台及基因模式动物平台。百奥赛图的RenMice平台涵盖两个全人源转基因小鼠系列(RenMab及RenLite),在全球拥有多元化客户群。营业纪录期间,公司已与14家知名制药企业(例如德国默克、美国Xencor、百济神州、君实生物、信达生物等)达成授权及试验合作协议。基因编辑技术驱动双业务线并举 不断扩宽收入来源百奥赛图凭藉专有基因编辑技术、转基因小鼠平台和高通量体内抗体发现平台为依托,生成综合动物病患模型,进而以动物模型为基础为国内外客户提供模式动物以及临床前药理药效CRO服务。根据弗若斯特沙利文的资料,营业纪录期间,百奥赛图与全球前10大制药公司中的9家建立长期的合作关系,并为全球200多家合作伙伴完成了500多个药物评价项目。于2021年,公司海外销售收入占比高达36%。2022年前4个月,该比重进一步提升至超过45%。可以预期,该等模式有望不断拓宽公司的盈利渠道,为其带来源源不断的收入。基于自主研发并拥有完全独立知识产权的全人抗体RenMice平台,百奥赛图将单抗和双抗开发技术平台、动物体内药效筛选平台、强大的临床开发能力有机整合在一起,形成了独具特色、涵盖药物研发全流程的新药研发体系。百奥赛图致力于与全球合作伙伴一起通过技术与思路的创新实现新药开发的目标,公司启动了大规模体内抗体发现和筛选计划-“千鼠万抗”计划并建立起强大的临床及临床前产品管线,通过合作开发/转让开发大大加速药物研发进程。截至2022年4月底,已对外转让/合作24个抗体分子,合作方包括荣昌生物、华润生物、日本Liberothera等。同时,自主研发的YH003和YH001创新药物分子进入国际多中心临床II期,优异的临床数据很好的验证了其体内药物筛选模式,极具行业壁垒。盈利能力稳健持续提升 在港上市有望继续扩大市场份额财务方面,百奥赛图的收益主要来自于提供基因编辑服务、临床前药理药效评价、模式动物销售及抗体开发。于2021年,该公司实现收入3.55亿元,较2020年增长40%;2022年前4个月,实现收入1.17亿元,较2021年同期增长达到67%。公司毛利率持续稳定增加,在2020-2021年期间分别为65.9%及69.8%,接近70%的高毛利率远超同业。特别是抗体发现业务发展迅猛,2021年度百奥赛图的抗体业务同期增速达115%,数据十分亮眼。作为市场中掌握着基因编辑独特技术且有营收的生物技术公司,百奥赛图具备世界一流的服务、技术及产品,此次登陆港交所,有望在香港资本市场的强大助力下,深入推进全球化布局,进而扩大业务规模及市场份额,实现更高的战略目标,创造更丰厚的商业回报。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More